TOOLS FOR TOMORROW’S TISSUE ENRICHMENT

Raven Biosystems is developing laboratory systems that make tissue enrichment much faster, more consistent, and less costly than manual microdissection—enabling better molecular analysis at scale.

About

We see a future where tissue enrichment is no longer slow, inconsistent, or limited by manual techniques. Raven aims to set a new standard—delivering high-quality, high-resolution enrichment that’s accessible to every lab.Raven Biosystems is an independent, founder-led company based in Washington state. We prioritize research, quality, and clinical impact—building practical tools that solve real problems in the pathology lab.Our first product is expected in 2026.

TEAM

We're building an exceptional team. If you think you might be a great fit, reach out through our contact form. We'd love to hear from you!

Erik Henne

Founder & CEO

Erik brings over 20 years of hands-on experience in medical-device innovation, leading projects from concept to commercialization. He co-founded Morair Medtech, developed FDA-designated Class III breakthrough devices for lung diseases and holds multiple patents in therapeutic technologies. At Raven Biosystems, Erik leads development and strategy toward the company's 2026 launch.

Contact

Have questions, ideas, or an interest in working with us? We’re always open to thoughtful conversations and future collaborators.